Skip to content

Clinical trials

Neoplasms by Site trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Czechia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20142
20151
20162
20181
20191
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.2
Abbott1
AstraZeneca1
Celgene1
Daiichi Sankyo1
Eli Lilly and Company1
Hoffmann-La Roche1
Karyopharm Therapeutics Inc1
Novartis Pharmaceuticals1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms11
Neoplasms by Site11
Digestive System Diseases4
Digestive System Neoplasms4
Adenocarcinoma3
Breast Diseases3
Breast Neoplasms3
Bronchial Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Lung Diseases3

Trials

Showing 51 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.